三维超声心动图心脏容积评估对计划植入左心室辅助装置患者的预后价值
本研究为单中心非随机诊断性队列研究,纳入65例计划植入左心室辅助装置的患者,采用三维经食管超声心动图定量评估左右心室容积并与临床结局相关分析。主要终点为60天死亡率,结果显示60天非幸存者二维超声右/左舒张末期比值更高,而幸存者左室、右室及整体心脏指数化舒张末期容积更高;右室指数化舒张末期容积>82 ml/m2组1年生存更好。
要点
- 60天非幸存者二维超声右/左舒张末期比值显著高于幸存者(0.70 ± 0.09 vs 0.62 ± 0.11,P = 0.01)。
- 60天幸存者左室、右室及整体心脏指数化舒张末期容积均显著高于非幸存者。
- 右室指数化舒张末期容积>82 ml/m2组1年生存优于≤82 ml/m2组(P = 0.005)。
核心结论
- 右室舒张末期容积指数中度增加的患者术后风险较高,而严重右室扩张似乎具有保护作用。
研究设计与样本
- 单中心、非随机诊断性队列研究,前瞻性收集65例计划植入左心室辅助装置(使用离心泵长期支持,HeartWare和HeartMate 3)患者的临床和三维超声心动图数据。
主要发现
- 60天幸存者49例(75%),非幸存者16例(25%)。
- 60天非幸存者二维超声右/左舒张末期比值显著高于幸存者(0.70 ± 0.09 vs 0.62 ± 0.11;P = 0.01)。
- 60天幸存者左室指数化舒张末期容积显著高于非幸存者(154 ± 51 ml/m2 vs 110 ± 40 ml/m2,P = 0.004)。
- 60天幸存者右室指数化舒张末期容积显著高于非幸存者(96 ± 27 ml/m2 vs 80 ± 23 ml/m2,P = 0.05)。
- 60天幸存者整体心脏指数化舒张末期容积显著高于非幸存者(250 ± 64 ml/m2 vs 190 ± 57 ml/m2,P = 0.003)。
关键数值与推荐
- 逻辑回归分析显示,右/左舒张末期比值和右室指数化舒张末期容积与60天死亡率相关。
- 右室指数化舒张末期容积>82 ml/m2组与≤82 ml/m2组的Kaplan-Meier生存曲线显示,右室扩张更明显组1年生存更好(P = 0.005)。
临床怎么用
- 作者认为,未来对右室中度扩张患者的术后管理应侧重于个体化调整合适的左心室辅助装置流量并提供频繁随访。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Left ventricular assist device (LVAD) support is an increasingly important and successful therapeutic option for patients with end-stage heart failure. As chronic heart failure progresses, the left and right ventricles adapt by enlarging its volume and patients present for LVAD implantation with varying degrees of dilatation. By quantitatively assessing right ventricular (RV) and left ventricular (LV) volumes using 3D transoesophageal echocardiography and correlating the findings with clinical outcomes, we aim to investigate the prognostic value of LV and RV volumes for early survival after LVAD implantation. METHODS: This is a single-centre, non-randomized diagnostic cohort study using prospectively collected clinical and 3D echocardiographic data from 65 patients scheduled for LVAD implantation, using centrifugal pumps for long-term support (HeartWare and HeartMate 3). The primary end-point for this study is 60-day mortality, with longer term survival as a secondary end-point. RESULTS: We divided our cohort group into survivors and non-survivors at 60 days [49 patients (75%) and 16 patients (25%), respectively]. Right to left end-diastolic ratio assessed by 2D echocardiography was significantly higher in the 60-day non-survivors group (0.70 ± 0.09 vs 0.62 ± 0.11; P = 0.01). Indexed end-diastolic volume parameters (LV, RV and overall heart) showed significant differences among the groups and were higher in the 60-day survivors group (LV volume 154 ± 51 ml/m2 vs 110 ± 40 ml/m2, P = 0.004; RV volume 96 ± 27 ml/m2 vs 80 ± 23 ml/m2, P = 0.05; heart 250 ± 64 ml/m2 vs 190 ± 57 ml/m2, P= 0.003). To investigate haemodynamic and echocardiographic parameters, the right to left end-diastolic ratio and indexed RV end-diastolic volume were associated with 60-day mortality in the logistic regression analysis. The Kaplan-Meier survival curves for patients with indexed RV end-diastolic volume >82 ml/m2 vs indexed RV end-diastolic volume ≤82 ml/m2 showed better 1-year survival (P = 0.005) for the group with more RV dilatation. CONCLUSIONS: Patients with moderately increased end-diastolic RV volume index carry a higher postoperative risk, while severe RV dilatation seems to be protective. In future, postoperative management of patients with moderately dilated RVs should be focussed on adjusting individually appropriate LVAD flows and providing frequent follow-up.
引用
- Otten A, Kurz S, Anwar S, et al. Prognostic value of 3-dimensional echocardiographical heart volume assessment in patients scheduled for left ventricular assist device implantation. Eur J Cardiothorac Surg. 2018. PMID: 29394347. doi:10.1093/ejcts/ezy002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。